✦ LIBER ✦

A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC)

✍ Scribed by Raez, Luis E.; Santos, Edgardo S.; Webb, R. Timothy; Wade, James; Brito, Roger A.; Karr, Melissa; Kennah, Andra; Childs, Barrett H.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P-207 Docetaxel and irinotecan as first

✍ Groth, Gesine; Reck, Martin; Wilke, Hansjochen; Büchele, Thomas; Schäfer, Klaus; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 421 KB

793 Multicenter phase II study of gemcit

✍ F. Cappuzzo; S. Novello; F. De Marinis; M. Maur; G. Scagliotti; S. Salvagni; E. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 165 KB

Phase II study of docetaxel and cisplati

✍ Y. H. Kim; J. S. Kim; Y. H. Choi; K. H. In; H. S. Park; D. S. Hong; T. J. Jeong; 📂 Article 📅 2002 🏛 Springer 🌐 English ⚖ 67 KB

9149 Phase II study of bevacizumab in co

✍ Ferrer, N.; Cobo, M.; Paredes, A.; Méndez, M.; Muñoz-Langa, J.; Rueda, A.; de Mo 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB

First-line erlotinib and bevacizumab in

✍ Dingemans, A.- M. C.; de Langen, A. J.; van den Boogaart, V.; Marcus, J. T.; Bac 📂 Article 📅 2011 🏛 Oxford University Press 🌐 English ⚖ 383 KB

83 Phase II study of docetaxel (Taxotere

✍ Le Chevalier, T.; Mattson, K.; Bosquée, L.; Le Groumellec, A.; Stupp, R.; Monnie 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 162 KB